Pregnant women, who are among the priority vaccines as of Wednesday, face a difficult dilemma. The National Institute of Public Health recommends RNA vaccines for them, while acknowledging the lack of data on the safety of COVID-19 vaccines in their state.
The Lego government has now decided to prioritize pregnant women and, at the same time, people with disabilities or those struggling with chronic diseases, according to a National Institute of Public Health (INSPQ) conclusion received on Tuesday.
In his opinion, INSPQ writes that “vaccination against COVID-19 should be offered to a pregnant woman. For these women, the RNA vaccine is preferred given the more safety data available for this type of product. ”
INSPQ also writes that “the risk of complications from COVID-19 in pregnant women, although lower than in older people, is higher compared to the risk for women of the same age who do not.”
This risk is higher for pregnant women with pre-existing health problems such as diabetes or obesity. Pregnant women who have contracted COVID-19 are also reported to be more likely to give birth prematurely.
However, INSPQ indicates that we do not conduct clinical trials on pregnant or breastfeeding women. There are also no data on the safety of RNA vaccines in early pregnancy. “The National Advisory Committee on Immunization notes that it would be prudent to postpone pregnancy for at least 28 days” after vaccination.
By giving preference to pregnant women, the Quebec government thus supports the Society of Obstetricians and Gynecologists of Canada. Very concerned about the increase in the number of intensive care patients in Ontario in the past week, the organization has taken a firm stance in this direction.